Skip to content
Sign inOpen the app
Artwork for The Long Run with Luke Timmerman
The Long Run with Luke Timmerman · Dec 15, 2025 · 1 hr 7 min

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).

0:00-1:07:34
Play in podnod

transcript

No transcript — this publisher did not publish one.

show notes

Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).

more episodes

All episodes